This Seattle-based biotech, known for its immune medicine platform, reported a notable insider sale amid ongoing industry ...

Specialized laboratory relocation firm shares safety protocols and planning tips for moving precision instruments in ...

In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now. On April 13, Tom Lee, Fundstrat’s ...

Strong demand for GLP-1 drugs and next-gen diagnostic testing is pulling investors back into life sciences, even as AI soaks ...

In recent years, a specific therapeutic area has seen explosive demand, creating significant revenue opportunities for companies serving this field or developing potential products.

In the latest close session, Amgen (AMGN) was up +1.69% at $355.30. This move outpaced the S&P 500's daily gain of 1.2%. Elsewhere, the Dow gained 1.79%, while the tech-heavy Nasdaq added 1.52%. Prior ...

The trading gives Waltham-based Kailera a market value of almost $3.1 billion based on the outstanding shares listed in its ...

Weight-loss drug developer ​Kailera Therapeutics' shares surged 62.5% in their Nasdaq debut on Friday ‌after closing a $625 ...

Trevi Therapeutics shifts to late-stage biotech with Haduvio for IPF chronic cough. Click here to read my latest analysis of ...

The Fremont company sold extra shares at the top of its proposed range, and the stock jumped more than 30% in initial trading ...

Kailera Therapeutics Inc., a clinical-stage biotechnology company focused on obesity, raised $625 million in an upsized ...

Psyence Biomedical (PBM) stock exploded 203% on April 16, 2026, following White House ibogaine executive order news and ...